Why is Windlas Biotech falling/rising?

As of 29-Aug, Windlas Biotech Ltd's stock price is currently at Rs 990.80, reflecting a decrease of Rs 4.3 or 0.43%. The stock has underperformed its sector today by 0.46%, with an intraday high of Rs 1019.9. Over the past week, the stock has declined by 2.28%, and it has also seen a drop in delivery volume by 5.8% compared to the 5-day average, indicating falling investor participation. Despite a strong performance over the past year with a return of 21.28%, the stock's year-to-date performance shows a decline of 4.13%. The company has a low debt-to-equity ratio and has reported positive financial results, including record net sales and profits, but its premium valuation compared to peers and a high PEG ratio may be contributing to the current price decline.
In the broader market context, Windlas Biotech's short-term performance has been weaker than the benchmark Sensex, which has fallen by 1.84% over the same week. While the stock has consistently outperformed the BSE500 over the last three years, the recent underperformance against the benchmark and sector, combined with reduced trading volume, suggests a cautious sentiment among investors. The stock's current valuation and mixed performance metrics may be leading to a reassessment of its attractiveness, contributing to the recent decline in price.